ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Diclofenac Sodium Gel

Also written as “Diclofenac sodium gel 1%”, “Voltaren Gel” and “Diclofenac sodium gel”.

Its studies are mostly in Keratosis, Actinic · Osteoarthritis, Knee · Osteoarthritis · Pain · Myalgia, led by 8 companies.

Drug pageDiclofenac Sodium Gel: every studyMany companies study it; this page follows only the 11 they lead. All 20 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Sep 13, 200511 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Novartisits history only30 open or runningphase 3since Sep 13, 2005Sep 13, 2005none ahead
Amzellits history only20 open or runningphase 1since Jul 7, 2023Jul 7, 2023none ahead
Akornits history only10 open or runningphase 3since Sep 22, 2016Sep 22, 2016none ahead
Encube Ethicals Pvt.its history only10 open or runningphase 3since Jan 30, 2019Jan 30, 2019none ahead
Glenmark Pharmaceuticals Ltd. Indiaits history only10 open or runningphase 3since Nov 3, 2015Nov 3, 2015none ahead
HALEONits history only10 open or runningphase 4since Apr 18, 2024Apr 18, 2024none ahead
Sun Pharmaceutical Industries10 open or runningphase 1since Dec 3, 2012Dec 3, 2012none ahead
Viatrisits history only10 open or runningphase 3since May 30, 2017May 30, 2017none ahead

Also a collaborator on its studies: Novum Pharmaceutical Research Services.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Sun Pharmaceutical Industries only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Dec 3, 2012First study: phase 1 study in Keratosis, ActinicFirst studyNCT01742663 · 435 enrolled

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

The one study Sun Pharmaceutical Industries leads. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT01742663Keratosis, Actinic1CompletedJul 2013435

How it is read

Names in the registry

  • “Diclofenac Sodium Gel”, 3 entries
  • “Diclofenac sodium gel 1%”, 3 entries
  • “Voltaren Gel”, 1 entry
  • “Diclofenac sodium gel”, 1 entry
  • “Diclofenac sodium gel 3%”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.